Skip to content

May 17, 2024

Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline
Diasorin Secures FDA 510(k) Clearance for Enhanced Respiratory Panel
Seegene and Springer Nature Forge Strategic Partnership
Radiation oncology in the era of Precision Medicine

HOME
UPDATE
INSIGHT
TECHNOLOGY
IN FOCUS
CONTACT US

Infocus
Insight
Technology
Uncategorized
Update

Chief Editor

Dr Manisha Khurana

Transforming healthcare through precision medicine insights

HOME
UPDATE
INSIGHT
TECHNOLOGY
IN FOCUS
CONTACT US

Search for:

Home
Contact Us

Highlight News

Update

Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline

Update

Diasorin Secures FDA 510(k) Clearance for Enhanced Respiratory Panel

Update

Seegene and Springer Nature Forge Strategic Partnership

Insight

Radiation oncology in the era of Precision Medicine

Contact Us

`Get in touch with us for any inquiries or collaborations.`

Email :- contact@nextedge.in

Search

Recent Posts

Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline
Diasorin Secures FDA 510(k) Clearance for Enhanced Respiratory Panel
Seegene and Springer Nature Forge Strategic Partnership
Radiation oncology in the era of Precision Medicine
U.S. FDA Grants Approval to Bristol Myers Squibb’s Breyanzi CAR T Cell Therapy for Relapsed or Refractory Follicular Lymphoma
Indian Council of Medical Research (ICMR) Issues Protocol for Evaluating TB Detection Technologies: A Generic Concordance Study
Bayer Initiates Phase I Trial of Innovative Targeted Radionuclide Therapy, 225Ac-PSMA-Trillium, in Advanced Metastatic Prostate Cancer
Triumph Over SMA: A Story of Collective Effort and Medical Breakthrough
Leading Visionary in the field of Precision Oncology
Triomics Raises $15M to Automate Oncology Workflows with GenAI-Powered Platform

Categories

Infocus
Insight
Technology
Uncategorized
Update

Popular News

Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline

Update

Diasorin Secures FDA 510(k) Clearance for Enhanced Respiratory Panel

Update

Seegene and Springer Nature Forge Strategic Partnership

Update

Radiation oncology in the era of Precision Medicine

Insight

U.S. FDA Grants Approval to Bristol Myers Squibb’s Breyanzi CAR T Cell Therapy for Relapsed or Refractory Follicular Lymphoma

Update

Indian Council of Medical Research (ICMR) Issues Protocol for Evaluating TB Detection Technologies: A Generic Concordance Study

Update

Bayer Initiates Phase I Trial of Innovative Targeted Radionuclide Therapy, 225Ac-PSMA-Trillium, in Advanced Metastatic Prostate Cancer

Update

Triumph Over SMA: A Story of Collective Effort and Medical Breakthrough

Update

Trending News

Update

Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline 01

7 hours ago

02

Update

Diasorin Secures FDA 510(k) Clearance for Enhanced Respiratory Panel

03

Update

Seegene and Springer Nature Forge Strategic Partnership

Recent News

Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline

Update

Diasorin Secures FDA 510(k) Clearance for Enhanced Respiratory Panel

Update

Seegene and Springer Nature Forge Strategic Partnership

Update

Radiation oncology in the era of Precision Medicine

Insight

U.S. FDA Grants Approval to Bristol Myers Squibb’s Breyanzi CAR T Cell Therapy for Relapsed or Refractory Follicular Lymphoma

Update

Indian Council of Medical Research (ICMR) Issues Protocol for Evaluating TB Detection Technologies: A Generic Concordance Study

Update

Bayer Initiates Phase I Trial of Innovative Targeted Radionuclide Therapy, 225Ac-PSMA-Trillium, in Advanced Metastatic Prostate Cancer

Update

Triumph Over SMA: A Story of Collective Effort and Medical Breakthrough

Update

All Rights Reserve by Nextedge 2024. Powered By BlazeThemes.

Blog
Privacy
Contact